Deoxyribonucleic acid ploidy status as no basis for pathologic stage prediction in clinically resectable prostate cancer

By Egawa S.   Satoh T.   Iwamura M.   Aihara M.   Kuwao S.   Uchida T.   Koshiba K.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 548-552

Elsevier

Access to resources Recommend Favorite

Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation

By Martnez-Jabaloyas J.M.   Ruiz-Cerda J.L.   Hernandez M.   Jimenez A.   Jimenez-Cruz F.  

Urology, Vol. 59, Iss. 5, 2002-05 ,pp. : 715-720

Elsevier

Access to resources Recommend Favorite

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy

By Nakopoulou L.   Constantinides C.   Papandropoulos J.   Theodoropoulos G.   Tzonou A.   Giannopoulos A.   Zervas A.   Dimopoulos C.  

Urology, Vol. 46, Iss. 3, 1995-09 ,pp. : 334-340

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Tumor Ploidy and Histomorphological Parameters in Adenocarcinoma of Barrett’s Esophagus

By  

Digestive Surgery, Vol. 16, Iss. 3, 1999-07 ,pp. : 180-185

Karger

Access to resources Recommend Favorite

Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (pT3) prostate cancer after radical retropubic prostatectomy

By Hawkins C.A.   Bergstralh E.J.   Lieber M.M.   Zincke H.  

Urology, Vol. 46, Iss. 3, 1995-09 ,pp. : 356-364

Elsevier

Access to resources Recommend Favorite